BioLingus (Cayman) Limited (SUBL)
   BioLingus (Cayman) Limited will go public soon, but the exact IPO date is still unknown.
IPO Price
 $20.00
Shares Offered
 360,000
Deal Size
 $7.20M
SUBL Statistics
Total Valuation
SUBL has a market cap or net worth of $222.25 million. The enterprise value is $228.51 million.
| Market Cap | 222.25M | 
| Enterprise Value | 228.51M | 
Important Dates
| Earnings Date | n/a | 
| Ex-Dividend Date | n/a | 
Share Statistics
SUBL has 11.11 million shares outstanding.
| Current Share Class | n/a | 
| Shares Outstanding | 11.11M | 
| Shares Change (YoY) | n/a | 
| Shares Change (QoQ) | n/a | 
| Owned by Insiders (%) | n/a | 
| Owned by Institutions (%) | n/a | 
| Float | n/a | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| Forward PS | n/a | 
| PB Ratio | n/a | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
| Current Ratio | n/a | 
| Quick Ratio | n/a | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | -1.69 | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | n/a | 
| Return on Invested Capital (ROIC) | n/a | 
| Return on Capital Employed (ROCE) | n/a | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | -$38,986 | 
| Employee Count | 15 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
| Beta (5Y) | n/a | 
| 52-Week Price Change | n/a | 
| 50-Day Moving Average | n/a | 
| 200-Day Moving Average | n/a | 
| Relative Strength Index (RSI) | n/a | 
| Average Volume (20 Days) | n/a | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
| Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -616,807 | 
| Pretax Income | -584,786 | 
| Net Income | -584,786 | 
| EBITDA | -261,928 | 
| EBIT | -367,414 | 
| Earnings Per Share (EPS) | -$0.05 | 
Balance Sheet
The company has $98,469 in cash and $6.36 million in debt, giving a net cash position of -$6.26 million or -$0.56 per share.
| Cash & Cash Equivalents | 98,469 | 
| Total Debt | 6.36M | 
| Net Cash | -6.26M | 
| Net Cash Per Share | -$0.56 | 
| Equity (Book Value) | -7.66M | 
| Book Value Per Share | -0.69 | 
| Working Capital | -6.58M | 
Cash Flow
| Operating Cash Flow | -327,607 | 
| Capital Expenditures | n/a | 
| Free Cash Flow | -327,607 | 
| FCF Per Share | -$0.03 | 
Margins
| Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
SUBL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | n/a | 
| Shareholder Yield | n/a | 
| Earnings Yield | -0.26% | 
| FCF Yield | -0.15% | 
Analyst Forecast
| Price Target | n/a | 
| Price Target Difference | n/a | 
| Analyst Consensus | n/a | 
| Analyst Count | n/a | 
| Revenue Growth Forecast (5Y) | n/a | 
| EPS Growth Forecast (5Y) | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
| Altman Z-Score | n/a | 
| Piotroski F-Score | 1 |